Back to Search
DAVID QUENELLE, M.D.
M.D.
Otolaryngology Physician
NPI: 1710909791Individual
Specialties, Licenses & Credentials
Otolaryngology PhysicianPrimary
Otolaryngology
Code: 207Y00000X
G13985(CA)
Research & Publications (20)
Activities of certain 5-substituted 4'-thiopyrimidine nucleosides against orthopoxvirus infections.
PMID 19029322·Antimicrob Agents Chemother·2009
7-preclinical
Effect of an immune enhancer, GPI-0100, on vaccination with live attenuated herpes simplex virus (HSV) type 2 or glycoprotein D on genital HSV-2 infections of guinea pigs.
PMID 18573279·Antiviral Res·2008
7-preclinical
Isolation and characterization of cidofovir resistant vaccinia viruses.
PMID 18479513·Virol J·2008
7-preclinical
Effect of oral treatment with (S)-HPMPA, HDP-(S)-HPMPA or ODE-(S)-HPMPA on replication of murine cytomegalovirus (MCMV) or human cytomegalovirus (HCMV) in animal models.
PMID 18336926·Antiviral Res·2008
7-preclinical
Vaccinia virus lacking the deoxyuridine triphosphatase gene (F2L) replicates well in vitro and in vivo, but is hypersensitive to the antiviral drug (N)-methanocarbathymidine.
PMID 18321387·Virol J·2008
7-preclinical
Effect of oral treatment with hexadecyloxypropyl-[(S)-9-(3-hydroxy-2- phosphonylmethoxypropyl)adenine] [(S)-HPMPA] or octadecyloxyethyl-(S)-HPMPA on cowpox or vaccinia virus infections in mice.
PMID 17846137·Antimicrob Agents Chemother·2007
7-preclinical
Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses.
PMID 17724153·Antimicrob Agents Chemother·2007
7-preclinical
Efficacy of rifabutin-loaded microspheres for treatment of Mycobacterium avium-infected macrophages and mice.
PMID 17454031·Drug Deliv·2007
7-preclinical
Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice.
PMID 17116683·Antimicrob Agents Chemother·2007
7-preclinical
In vitro and in vivo evaluation of isatin-beta-thiosemicarbazone and marboran against vaccinia and cowpox virus infections.
PMID 16621041·Antiviral Res·2006
7-preclinical
Human cytomegalovirus UL27 is not required for viral replication in human tissue implanted in SCID mice.
PMID 16571131·Virol J·2006
7-preclinical
Activity and mechanism of action of N-methanocarbathymidine against herpesvirus and orthopoxvirus infections.
PMID 16569849·Antimicrob Agents Chemother·2006
7-preclinical
Effect of immunization with herpes simplex virus type-1 (HSV-1) glycoprotein D (gD) plus the immune enhancer GPI-0100 on infection with HSV-1 or HSV-2.
PMID 16288820·Vaccine·2006
7-preclinical
Genetically engineered herpes simplex viruses that express IL-12 or GM-CSF as vaccine candidates.
PMID 16243413·Vaccine·2006
7-preclinical
Evaluation of AD472, a live attenuated recombinant herpes simplex virus type 2 vaccine in guinea pigs.
PMID 15950327·Vaccine·2005
7-preclinical
Oral activity of a methylenecyclopropane analog, cyclopropavir, in animal models for cytomegalovirus infections.
PMID 15561852·Antimicrob Agents Chemother·2004
7-preclinical
Oral treatment of murine cytomegalovirus infections with ether lipid esters of cidofovir.
PMID 15328119·Antimicrob Agents Chemother·2004
7-preclinical
Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir.
PMID 15196818·Antiviral Res·2004
7-preclinical
Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.
PMID 14742188·Antimicrob Agents Chemother·2004
4-observational
Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.
PMID 14506041·Antimicrob Agents Chemother·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1701 4TH ST, SUITE 120
SANTA ROSA, CA 95404 - Phone
- (707) 523-7025
Quick Facts
- NPI
- 1710909791
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile